Lv71
4960 积分 2022-03-15 加入
Adjusting Barcelona Clinic Liver Cancer Staging System to the Evolving Landscape of Hepatocellular Carcinoma: A Look to the Future
7天前
已完结
Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology
7天前
已完结
Survival in Unresectable Hepatocellular Carcinoma Treated With a New Immune Checkpoint and Anti-angiogenic Drug Combination
7天前
已完结
Risk Factors for Liver Cancer and Chronic Liver Disease-related Death: Are Sugar Substitutes Better Than the Real Thing?
7天前
已完结
Surveillance for hepatocellular carcinoma in cirrhosis: End of monopoly for serum alpha fetoprotein
7天前
已完结
GLP-1 Receptor Agonists' Role in Reducing Hepatocellular Carcinoma Risk
7天前
已完结
Comments on “Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes”
7天前
已关闭
Insights into the protective role of GLP-1RAs in the treatment of type 2 diabetes mellitus: implications for hepatocellular carcinoma and hepatic dysfunction
7天前
已关闭
To look or not to look: A new score for stratifying patients at risk of developing HCC
7天前
已关闭
Reimagining Liver Cancer Allocation: Defining a New Vision
7天前
已关闭
皖公网安备34019202002308
